Drug
Tenofovir
Tenofovir: highest development phase Post-Market, developed by Gilead Sciences. 2 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Gilead Sciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tenofovir NCT02585947 | Post-Market | Non-Hodgkin's Lymphoma, Burkitt's |
| Tenofovir NCT01872988 | Phase 3 | Chronic Hepatitis B |
Latest
No recent events.
Follow Tenofovir on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.